These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Idazoxan-induced reductions in cortical glucose use are accompanied by an increase in noradrenaline release: complementary [14C]2-deoxyglucose and microdialysis studies. French N; Lalies MD; Nutt DJ; Pratt JA Neuropharmacology; 1995 Jun; 34(6):605-13. PubMed ID: 7566496 [TBL] [Abstract][Full Text] [Related]
5. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929 [TBL] [Abstract][Full Text] [Related]
6. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data. Rottenberg DA; Moeller JR; Strother SC; Dhawan V; Sergi ML J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493 [TBL] [Abstract][Full Text] [Related]
7. Cerebral glucose metabolic differences in patients with panic disorder. Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544 [TBL] [Abstract][Full Text] [Related]
8. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin. Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443 [TBL] [Abstract][Full Text] [Related]
9. Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomography. Schmidt ME; Goldstein DS; Schouten JL; Matochik JA; Kim HG; Potter WZ Psychopharmacol Bull; 1997; 33(2):253-9. PubMed ID: 9230639 [TBL] [Abstract][Full Text] [Related]
10. Age differences in intercorrelations between regional cerebral metabolic rates for glucose. Horwitz B; Duara R; Rapoport SI Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930 [TBL] [Abstract][Full Text] [Related]
11. The metabolic topography of normal aging. Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Mandel F; Alexander GE; Grady C; Pietrini P; Eidelberg D J Cereb Blood Flow Metab; 1996 May; 16(3):385-98. PubMed ID: 8621743 [TBL] [Abstract][Full Text] [Related]
12. [Tomographic measurement of human cerebral glucose metabolism]. Iwasaki Y; Konishi J; Makada Y; Yonekura Y Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247 [No Abstract] [Full Text] [Related]
13. The current status of PET scanning with respect to schizophrenia. Sedvall G Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021 [TBL] [Abstract][Full Text] [Related]
14. Generalized decrease in brain glucose metabolism during fasting in humans studied by PET. Redies C; Hoffer LJ; Beil C; Marliss EB; Evans AC; Lariviere F; Marrett S; Meyer E; Diksic M; Gjedde A Am J Physiol; 1989 Jun; 256(6 Pt 1):E805-10. PubMed ID: 2786677 [TBL] [Abstract][Full Text] [Related]
15. Regional cerebral glucose metabolism compared in rodents and humans. Blin J; Ray CA; Chase TN; Piercey MF Brain Res; 1991 Dec; 568(1-2):215-22. PubMed ID: 1814569 [TBL] [Abstract][Full Text] [Related]
16. Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant. Thorp PS; Levin SD; Garnett ES; Nahmias C; Firnau G; Toi A; Upton AR; Nobbs PT; Sinclair JC Neuropediatrics; 1988 Aug; 19(3):146-53. PubMed ID: 3265490 [TBL] [Abstract][Full Text] [Related]
17. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study. Miura SA; Schapiro MB; Grady CL; Kumar A; Salerno JA; Kozachuk WE; Wagner E; Rapoport SI; Horwitz B J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712 [TBL] [Abstract][Full Text] [Related]
18. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions. Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185 [TBL] [Abstract][Full Text] [Related]
19. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529 [TBL] [Abstract][Full Text] [Related]
20. Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings. Kluin KJ; Gilman S; Markel DS; Koeppe RA; Rosenthal G; Junck L Ann Neurol; 1988 Jun; 23(6):547-54. PubMed ID: 3261572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]